Petco Health reported flat revenue of $1.49 billion in Q2, with operational improvements mainly due to one-off tariff refunds rather than growth in its core business. The company's financial position remains strained, carrying $1.46 billion in long-term debt and a low interest coverage ratio of 1.5x, indicating ongoing risk. Management reaffirmed full-year 2026 guidance, factoring in tariff refunds, but Q3 adjusted EBITDA guidance of $100–$103 million is lower than Q2, which has dampened investor confidence. The analyst maintains a neutral outlook, awaiting clearer signs of sustained operational improvement before considering a positive rating change.
Conflux (CFX) experienced a significant short-term price surge, briefly moving above the $0.072 USDT mark early Sunday. At 4:51 a.m. ET, the token was trading at $0.06936 USDT, maintaining a 24-hour gain of over 35%. This sharp increase highlights st...
Albemarle, the world's largest lithium producer, saw its share price fall 40% due to lower lithium prices but reported a 20-fold increase in Q2 profits and strong free cash flow of $638 million. The company also reduced net debt to around $300 millio...
Ether (ETH) surpassed the key $2,500 price level on Binance's spot market, reaching $2,501 at 4:43 a.m. ET on Sunday. This marks a slight increase from $2,500 just 15 minutes earlier, despite a minor 0.01% dip compared to an hour before. The move abo...
Chainlink (LINK) traded around $12.86 to $12.93 on Binance, staying below its short-term moving averages but above longer-term ones, indicating no clear directional momentum. Key support levels are at $12.71 and $12.56, with resistance at $13.13 and ...
Ether (ETH) is showing signs of forming an Adam and Eve bottom pattern on its 10-minute chart, with a key resistance level at $2,520. A sustained close above this neckline could confirm a bullish breakout, potentially pushing the price toward the $2,...
